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Abstract
Background: For decades, semiquinone intermediates have been suggested to play an essential role in catalysis by
one of the most enigmatic proton-pumping enzymes, respiratory complex I, and different mechanisms have been
proposed on their basis. However, the difficulty in investigating complex I semiquinones, due to the many different
enzymes embedded in the inner mitochondrial membrane, has resulted in an ambiguous picture and no consensus.
Results: In this paper, we re-examine the highly debated origin of semiquinone species in mitochondrial membranes
using a novel approach. Our combination of a semi-artificial chimeric respiratory chain with pulse EPR spectroscopy
(HYSCORE) has enabled us to conclude, unambiguously and for the first time, that the majority of the semiquinones
observed in mitochondrial membranes originate from complex III. We also identify a minor contribution from complex II.
Conclusions: We are unable to attribute any semiquinone signals unambiguously to complex I and, reconciling our
observations with much of the previous literature, conclude that they are likely to have been misattributed to it. We note
that, for this earlier work, the tools we have relied on here to deconvolute overlapping EPR signals were not available.
Proposals for the mechanism of complex I based on the EPR signals of semiquinone species observed in mitochondrial
membranes should thus be treated with caution until future work has succeeded in isolating any complex I semiquinone
EPR spectroscopic signatures present.
Keywords: NADH:ubiquinone oxidoreductase, Respiratory complex I, Semiquinones, Electron paramagnetic resonance
Background
Respiratory complex I (NADH:ubiquinone oxidoreduc-
tase) is a crucial component of the mitochondrial electron
transport chain and thus plays a central role in energy
conversion and cellular metabolism [1–3]. Complex I ca-
talyses the oxidation of NADH and the reduction of ubi-
quinone, coupled to the translocation of four protons
across the inner mitochondrial membrane in a mechanism
that remains enigmatic, despite recent structural advance-
ments [4]. The current consensus is that the binding and
reduction of ubiquinone form an important mechanistic
element, but while mechanisms for the long-range coup-
ling that links electron transfer to proton translocation
have been proposed on the basis of computational models
[5–7], direct experimental evidence for them is lacking.
The key ubiquinone reduction step in catalysis must
proceed via a semiquinone (SQ) radical, given that the
iron-sulphur (Fe-S) clusters linking the two substrate
binding sites are single electron carriers. It is thus no
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surprise that, over the past four decades, electron para-
magnetic resonance (EPR) spectroscopy has been used
extensively to investigate the SQ species associated with
complex I. However, despite numerous reports of SQ
catalytic intermediates forming during turnover [8–12],
fundamental disagreements and inconsistencies have led
to ambiguity about the importance of SQs in the energy
coupling reaction of complex I [13]. Indeed, the stability
of the SQs generated during turnover has recently been
questioned [14], suggesting that SQs formed do not, in
fact, accumulate sufficiently to enable them to be
trapped and observed on an experimentally accessible
timescale. Given that different mechanisms have been
proposed on the basis of different ubiquinone reduction
pathways [15–17], a re-investigation of the putative SQs
associated with complex I is now warranted.
Most studies of complex I SQs have been con-
ducted in mammalian submitochondrial particles
(SMPs), inverted membrane vesicles that both main-
tain the structural integrity of the inner mitochondrial
membrane and allow the NADH substrate to be pro-
vided directly for complex I catalysis in vitro. How-
ever, SMPs contain the entire complement of inner
membrane enzymes (including many enzymes not dir-
ectly associated with the electron transfer chain) and
so any EPR signals observed are difficult to assign to
specific enzymes. Assignments of SQs have relied on
(1) the inhibition of enzymes downstream of complex
I, removing SQs from their sites but invoking second-
ary effects through inhibition of turnover and alter-
ation of the redox status of the Q-pool, and (2) an
exogenous ubiquinone analogue (Q1) [10, 11], which
has subsequently been shown to also react adventi-
tiously at the complex I flavin (NADH binding) site
[18]. Robust investigations of complex I SQs thus re-
quire sustained turnover conditions that both replen-
ish the Q-pool and rely on only the natural, highly
hydrophobic ubiquinone substrate.
Two SQs are typically attributed to complex I in
SMPs, distinguished on the basis of their relaxation
properties obtained from EPR measurements: fast-
relaxing (SQNf) and slow-relaxing (SQNs) [10, 11].
SQNf is reported to form only when a substantial
proton-motive force (Δp) is present across the inner
mitochondrial membrane [10], and to interact with
the nearby terminal Fe-S cluster (N2) [8, 19]. How-
ever, very particular conditions have been reported to
be required for the clear observation of SQNf and the
SQ-N2 interaction. SQNs has been reported in SMPs
in the absence of Δp [9] and assigned to complex I
based on its sensitivity to complex I Q-site inhibitors,
and because it is absent when complex I is in the
deactive state [8]. Notably, neither signal has been
clearly observed in any purified enzyme system, so
that their assignments to complex I have never been
proven. Investigations using complex I in proteolipo-
somes [12, 20] have only provided much lower SQ
signal intensities and occupancies than observed in
SMPs: < 0.1 μM SQ species and ~ 2% total occupancy
[12], compared to ~ 2.5 μM and ~ 100% occupancy
[10] in SMPs. The lack of clear evidence for the as-
signment of observed SQ species to complex I in
SMPs demands further investigation into their origins.
Here, we used the hitherto-unexploited approach of
constructing a chimeric respiratory chain from SMPs
and an alternative ubiquinol oxidase, to enable targeted
inhibition of enzymes downstream of complex I while
maintaining its turnover with the native ubiquinone sub-
strate (Fig. 1). This approach circumvents the misleading
effects resulting from soluble quinone analogues, and al-
lows the contributions of SQs from other respiratory
chain elements to be probed. Although a chimeric re-
spiratory chain using SMPs and the purified cytochrome
bd complex from Escherichia coli has been described
previously [21], it is unsuitable for SQ studies owing to
the very stable and therefore dominant cytochrome bd
SQ [22, 23]. Addition of the alternative oxidase (AOX)
from Trypanosoma brucei brucei to SMPs creates
‘AOX-SMPs’, containing a quinone-cycling system be-
tween complex I and AOX and with NADH:O2 turn-
over sensitive to complex I inhibitors (such as
piericidin A and rotenone) and the AOX inhibitor
ascofuranone [24, 25]. As no SQ intermediates have
been detected by EPR spectroscopy in wild-type AOX
[26, 27], incorporation of this terminal oxidase into
SMPs represents an intriguing new platform to inves-
tigate the SQs that are generated during sustained
NADH oxidation by complex I.
Fig. 1 Quinone cycling in AOX-SMPs during NADH oxidation. (Top)
Flow diagram showing the routes of quinol (QH2) production and
oxidation and their inhibitor sensitivities. Radicals (•) indicate
expected formation of semiquinones. (Bottom) AOX-SMPs support
NADH:O2 turnover through both the canonical chain and the
complex I-AOX pathway
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Results
SMPs and AOX-SMPs are well coupled and sustain a
proton-motive force
The variation in SQs observed previously in different
preparations of SMPs demands careful characterisa-
tion of our membrane system. The SMPs used here
(see [28, 29]) are capable of NADH- and succinate-
driven ATP synthesis and ATP hydrolysis and are in-
trinsically well coupled without additional coupling
factors, so they are a physiologically relevant system
for studying SQ formation. The addition of AOX pro-
vides a rapid secondary quinol oxidation route (Fig. 1),
such that NADH:O2 turnover is capable of exceeding
turnover by the canonical respiratory chain in an
AOX-concentration dependent manner [24, 25]. Thus,
to prevent the substrate from becoming exhausted
and ensure turnover during EPR sample preparation,
AOX was titrated to a low level, at which the flux
through the complex I-AOX pathway matched that
through the canonical chain (Additional file 1, Figure
S1). Representative catalytic properties for the original
SMPs and the rate-matched AOX-SMPs are given in
Table 1. In line with previous studies [28, 29], RCR
values of 1.6 to 3.0 were typically observed in the ab-
sence of AOX, and substantial rates of NAD+ reduc-
tion (reverse electron transfer, RET, driven by a
reduced Q-pool formed by succinate oxidation and a
proton-motive force (Δp) formed by ATP hydrolysis)
were observed in both cases (Table 1). The value of
Δp established by ATP hydrolysis (~ 160 mV, Table 1)
was determined by varying the potential of NADH:fu-
marate oxidoreduction, and matches previously re-
ported values [24, 28]. Therefore, the loss of the RCR
in AOX-SMPs does not arise from a loss of coupling,
since the Δp supported by ATP hydrolysis is shown
to be substantial and near identical to that in the ori-
ginal SMPs.
The proton-pumping capacity of AOX-SMPs was fur-
ther visualised through quenching of ACMA fluores-
cence during NADH:O2 turnover (Fig. 2). Substantial
quenching was observed in AOX-SMPs upon addition of
NADH. The addition of antimycin A (either before or
after NADH addition) causes a partial ablation of the
ACMA fluorescence quenching due to continued cataly-
sis and proton pumping by complex I. A combination of
antimycin A and the specific AOX inhibitor ascofura-
none fully ablates quenching. Following prior incubation
with antimycin A, the level of ACMA quenching from
complex I turnover is approximately 30–40% of the
quenching without any inhibitor, as expected for the
rate-matched AOX-SMPs from the established stoichi-
ometry [29]. Quenching was fully sensitive to complex I
inhibition by piercidin A, as well as to uncoupling to dis-
sipate Δp (Additional file 2, Figure S2). Levels of ACMA
quenching were identical in both SMPs and AOX-SMPs
(Additional file 2, Figure S2) in the absence of inhibitors,
and ACMA quenching by SMPs and AOX-SMP during
ATP hydrolysis matches closely (Additional file 2, Figure
S2). This further demonstrates that the coupling of the
membrane is retained in the AOX system.
Table 1 Representative kinetic measurements on SMPs and AOX-SMPs. AOX-SMPs were preincubated with antimycin A. For assay
details, see “Methods”
NADH:O2 (μmol min
− 1 mg− 1) Succinate:NAD+ (RET) (μmol min− 1 mg− 1) Inhibition of NADH oxidation (%) Δp (mV)
−Gram +Gram RCR −Gram +Gram Piericidin A Quinol oxidationa
SMPs 0.301 ± 0.008 0.626 ± 0.011 2.08 ± 0.05 0.092 ± 0.004 0.009 ± 0.001 98.7 ± 0.01 95.8 ± 0.03 161.4 ± 0.2
AOX-SMPs 0.288 ± 0.026 0.360 ± 0.028 1.25 ± 0.03 0.065 ± 0.004 0.007 ± 0.005 99.2 ± 0.01 97.1 ± 0.01 157.9 ± 1.6
aQuinol oxidation was inhibited by antimycin A in SMPs, and antimycin A and ascofuranone in AOX-SMPs
Fig. 2 The effect of oxidase pathway inhibitors on quenching ACMA
fluorescence in AOX-SMPs. ACMA fluorescence quenching was
measured (excitation at 419 nm, emission at 484 nm) during
NADH:O2 turnover in AOX-SMPs. The rate of coupled NADH
oxidation in AOX-SMPs was rate-matched as in Additional file 1,
Figure S1. Measurements were performed with constant stirring at
32 °C in a buffer containing 10 mM Tris-SO4, 50 mM KCl. In total,
50 μg/mL of SMPs or AOX-SMPs were added to a mixture
containing 0.5 μM ACMA and 0.1 μM valinomycin. NADH was added
to 500 μM. Turnover was inhibited by addition of antimycin A (2 μM)
and/or ascofuranone (2 μM) as indicated
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The g ~ 2 EPR signal in the presence of O2 in SMPs
In agreement with previous work [30], a large radical
signal is observed at g ~ 2 (Fig. 3) upon addition of
NADH to SMPs supplemented with additional O2.
This signal is almost negligible in SMPs not supple-
mented with O2 (Additional file 3, Figure S3), and it
is typically attributed to SQs arising from the respira-
tory chain complexes. The relatively narrow linewidth
(~ 9 G) defines the signal as arising from one or more
SQ species, rather than a complex I flavosemiquinone,
as this would exhibit a broader linewidth (> 15 G) [31,
32]. The other EPR signals are primarily due to Fe-S
clusters in complex I (referred to using the Nx no-
menclature) and the other respiratory complexes,
which are predominantly reduced during turnover.
Due to their faster relaxation compared to the g ~ 2
radical signal, which makes the radical signal stand
out more at lower power (0.02 mW), the Fe-S signals
are best observed at lower temperature (16 K). At
higher temperature (40 K), the slowest-relaxing com-
plex I [2Fe-2S] cluster N1b dominates the Fe-S region
of the spectrum, alongside the prominent g ~ 2 signal.
The broad dip in the same region from the oxidised
Cua centre of complex IV (most prominently observed
at 16 K owing to the fast relaxation of the Cua centre)
confirms the sustained turnover condition [33] in the
presence of O2.
Assignment of the g ~ 2 EPR signal through inhibition
studies
To assign the origin of the prominent g ~ 2 EPR signal, a
series of AOX-SMP samples were prepared containing
different inhibitors (Fig. 4). AOX-SMP samples were
chosen rather than SMP samples because turnover in
the presence of inhibitors can only be sustained by
employing the chimeric respiratory chain (Fig. 1). Akin
to what is observed for SMPs, the g ~ 2 EPR signal in-
creases substantially in intensity in the presence of add-
itional O2 (Fig. 4A, B). Note that all spectra in Fig. 4
were recorded at a high microwave power (2.02 mW) to
use the (fast-relaxing) Fe-S cluster signals for reference.
Carboxin, a complex II inhibitor, ablated a contribution
observed most clearly at g = 1.99 (more clearly seen at
12 K, see Fig. 5) that results from a well-documented
SQ-SQ radical pair in the complex II Q-site [34, 35] and
is a consequence of the highly reduced Q-pool during
NADH:O2 turnover (Fig. 1). However, carboxin had little
effect on the overall g ~ 2 signal (compare Fig. 4B, C and
see Additional file 4, Figure S4 for the dependence of
signal intensity on microwave power). Antimycin A, a
Fig. 3 X-Band continuous-wave EPR spectra of oxygen-supplemented SMPs reduced with NADH. The sample was reduced by 15 mM NADH (final
concentration) to approximately 25 mg/mL SMPs under continuous O2 flow in the absence of any inhibitor. Following mixing, the sample was
flash-frozen within 7 s (see “Methods”). All spectra have been normalised by the square root of the microwave power, and both panels are shown
at the same relative intensity. Vertical lines show the principle g values for the Fe-S clusters of complex I
Wright et al. BMC Biology           (2020) 18:54 Page 4 of 13
complex III Qi site inhibitor, diminished the g ~ 2 signal
intensity substantially (Fig. 4D). The major SQ species
present during NADH oxidation (note that complex I
turnover continues in the presence of antimycin A, due
to the presence of AOX) must therefore arise from com-
plex III. Finally, the complex I specific Q-site inhibitor
piericidin A effectively eliminates the g ~ 2 signal
(Fig. 4E) because it prevents quinone reduction and SQ
radicals forming anywhere in the chain. Therefore, the g
~ 2 signal comprises (at least) three distinct SQ species:
the major contribution is from complex III, there is a
lesser contribution from complex II, and a further minor
contribution (revealed by comparison of Fig. 4D and E)
that may be, but is not proven to be, from complex I.
Exploiting sustained turnover to investigate the possible
complex I SQ
Being as the AOX-SMP system enables steady-state
complex I turnover independently of complex III, we
reasoned that any g ~ 2 SQ signals from complex I in
the presence of NADH (with complexes II and III inhib-
ited) should be retained in AOX-SMPs (complex I is
turning over) but not in SMPs (complex I is not turning
over). Figure 6 shows that the g ~ 2 signal observed is
larger in AOX-SMPs compared to SMPs (the increase is
small but highly consistent) and that it is amplified over
time but does not increase further with prior activation of
complex I. The relative increase in the g ~ 2 signal in AOX-
SMPs over time is thus unlikely to result from activation of
complex I and could result from evolution of the oxidation
state of the ubiquinone pool. However, the presence of any
g ~ 2 signal in SMPs that are not undergoing turnover is
surprising: complex II/III-inhibited SMPs should emulate
the anaerobic condition in which the ubiquinone pool sim-
ply becomes fully reduced by NADH (Fig. 6, top spectrum),
and therefore the g ~ 2 signal intensity is expected to be in-
significant. The origin of the g ~ 2 signal in Fig. 6, which
thus appears to be stabilised or induced by the presence of
O2, is therefore unclear. Its sensitivity to piericidin A in
AOX-SMPs (Fig. 4E) make it tempting to assign it to com-
plex I, but its presence in SMPs inhibited with antimycin A
means that downstream effects mediated by changes in the
potential of the ubiquinone pool, perhaps in other Q-linked
enzymes, cannot be excluded.
Using hyperfine spectroscopy to distinguish overlapping
SQ signals
As X-band CW EPR spectroscopy cannot unambigu-
ously distinguish different SQ species (their g values and
linewidths are too similar), we employed hyperfine spec-
troscopy to differentiate the SQs on the basis of the sur-
rounding nuclear spins (14N, I = 1) coupled to the
Fig. 4 X-band continuous-wave EPR measurements of AOX-SMPs during NADH:O2 turnover in the presence of respiratory chain inhibitors. 16 K (left)
and 40 K (right) EPR spectra of AOX-SMPs (25mg/mL SMP protein and 0.01mg AOX mg− 1) reduced by 20mM NADH in presence of the inhibitors
marked and supplemented by additional O2 flow where stated. Sample A was prepared aerobically, without additional O2. The main respiratory chain
enzymes that contribute to the SQ signal at g ~ 2 in each sample are indicated on the right-hand panel. Inhibitor concentrations: 100 μM carboxin
(complex II Q-site inhibitor), 100 μM antimycin A (complex III Qi site inhibitor),100 μM piericidin A (complex I Q-site inhibitor). EPR measurement
conditions: 2.02 mW microwave power
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electron spin. Equivalent but more concentrated (~ 2x)
samples than those shown in Fig. 4 were prepared for
HYSCORE spectroscopy. The 14N regions of the 40 K
HYSCORE spectra of carboxin-treated, and carboxin-
and antimycin A-treated samples are shown in Fig. 7.
Whereas the spectrum from the complex II-inhibited
sample exhibits two sets of 14N cross peaks at [3.1, 4.3]
MHz and [3.0, 2.1] MHz (Fig. 7a), the latter peaks are ab-
sent when both complex II and III are inhibited (Fig. 7b).
Indeed, the HYSCORE difference spectrum reveals a sin-
gle set of 14N cross peaks (Fig. 7c) that could be simulated
(Fig. 7d) with hyperfine and quadrupolar parameters that
are highly consistent with those determined for the
strongly H-bonded Qi site SQ radical in complex III iso-
lated from Rhodobacter sphaeroides which forms an inter-
action with the Nε of a histidine (Additional file 6, Table
S1) [36]. Therefore, the HYSCORE measurements enable
unambiguous assignment of the antimycin A-sensitive SQ
species to complex III, consistent with the conclusion
from CW measurements (Fig. 4) that the major SQ radical
stabilised in SMPs during NADH:O2 turnover arises from
complex III. The complete simulation of the 14N environ-
ment of the SQ in carboxin-inhibited SMPs is given in
Fig. 8a.
The quadrupole coupling parameters (κ and η—see
Eq. 3) of 14N nuclei can be highly informative as to the
type of nitrogen interacting with the electron spin
(Fig. 8b). The prominent set of cross peaks at [3.1, 4.3]
MHz present in both samples could be simulated well
with hyperfine and quadrupole parameters that are typ-
ical of backbone amide 14N (Fig. 8a, see also Add-
itional file 6, Table S1), as revealed by comparison with
the 14N quadrupole parameters of known protein-bound
SQs (Fig. 8b). Given that contributions from the Fe-S
clusters (specifically N1b, see ref. [38]) are minimal rela-
tive to the contributions from the g ~ 2 signal (shown by
measurements conducted off-resonance from the g ~ 2
SQ signal, see Additional file 7, Figure S6 and
Additional file 8, Figure S7), these 14N modulations must
originate from a SQ radical. It is tempting to attribute
the cross peaks to complex I SQ (given that complex II
is inhibited in both samples), but their generic spectro-
scopic signature necessitates caution and a definitive as-
signment cannot be made.
Discussion
The AOX-SMPs used here have enabled us, for the
first time, to investigate the effects of respiratory
chain inhibitors on SQ species formed downstream of
complex I, while sustaining complex I turnover with
its native ubiquinone substrate. Many previous studies
into complex I SQs have refrained from using inhibitors
due to emphasis on the requirement for sustained turn-
over [8, 30, 39]. However, SQs can be stabilised by com-
plexes I, II [35, 40, 41] and III [36, 42, 43], as well as by
many other candidate off-pathway enzymes, so inhibitors
have a crucial part to play in dissecting their origins. In-
hibitors have been combined with NADH:Q1 turnover,
but Q1 and other soluble ubiquinone analogues are known
to react at the complex I flavin site through SQ
Fig. 5 The effect of carboxin on complex II semiquinone signals at
12 K. AOX-SMPs were prepared and measured as in Fig. 4 but at 12
K. Vertical lines indicate g values for the SQ-SQ radical pair of
complex II as previously reported [34]
Fig. 6 Comparison of SQ EPR signals in antimycin A- and carboxin-
inhibited SMPs and AOX-SMPs. X-band EPR spectra of SMPs (red)
and AOX-SMPs (black, 0.01 mg AOX mg− 1) frozen immediately or
following a 2-min incubation with 40 mM NADH under high O2
flow. Samples were treated with 100 μM carboxin and 100 μM
antimycin A. Pre-activated samples were mixed with 1 mM NADH
and incubated at room temperature for 5 min in an aerobic
atmosphere prior to EPR sample preparation. The anaerobic AOX-
SMP sample was incubated in a Braun UniLab-plus glovebox (O2 <
0.5 ppm, N2 atmosphere) at room temperature (22 °C) for 1 h prior
to addition of 20 mM NADH. The sample was frozen within 30 s of
substrate mixing. EPR measurement conditions: 2.02 mW microwave
power, 40 K
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intermediates in potentially misleading side reactions [18].
Our chimeric respiratory chain supports sustained com-
plex I turnover while avoiding these side reactions. Fur-
thermore, the membrane particles used here show
substantial proton-pumping capacity (without ‘induced
coupling’ by oligomycin or other poorly characterised
treatments) as demonstrated by ACMA fluorescence and
Δp measurements, and the AOX-SMP system has recently
been verified as a physiologically relevant model for oxida-
tive phosphorylation, with substantial rates of ATP syn-
thesis and confirmed proton-pumping stoichiometries
[24].
The majority of studies of SQ radicals in SMPs have
used deconvolution of power saturation curves to deter-
mine the number of SQ species present, along with their
relative relaxation rates. However, power saturation
curves are prone to overinterpretation, with better fits to
a single curve obtained by increasing the number of in-
dependently variable parameters [13], and they are
unable to localise species to any particular respiratory
chain component. Here we have used, for the first time,
pulse EPR methods to investigate the origin of SQs in
SMPs—methods that were not available when the first
investigations were carried out some 40 years ago.
HYSCORE measurements, combined with the modular
AOX-SMP system, allowed us to spectroscopically iso-
late the Qi site SQ in mammalian complex III for the
first time, providing details of specific nitrogen hydrogen
bonding interactions that closely resemble those in its
purple bacterial counterpart [44]. Figure 7 shows that
the quadrupolar parameters from the H-bonded com-
plex III SQi are distinctive, strongly supporting our as-
signment. Recent work on the complex III SQ allows us
to further qualify the type of complex III SQ we are ob-
serving. First, we consider the recently discovered Qo
site metastable SQ [45] to be an unlikely contributor to
the complex III g = 2.00 signal because Qo site SQs have
not been reported under steady-state aerobic conditions
in SMPs as employed here [43]. Two populations of SQ
are in principle possible in the Qi site, one with a dipolar
coupling interaction to the neighbouring oxidised (para-
magnetic) heme bH and another without magnetic coup-
ling to the reduced (diamagnetic) state of the heme [46].
The magnetically coupled Qi site SQ is not a contributor
under the measurement conditions employed here be-
cause its enhanced spin-lattice relaxation means that it
is only detectable at high temperature (200 K) and
microwave power [44, 46]. The slower relaxing
uncoupled Qi site SQ on the other hand can be formed
during the oxidation of ubiquinol at the Qi site and is
fully compatible with the spectroscopic properties of the
Qi site semiquinone generated here in SMPs.
Comparison of our observed CW EPR spectra with
known spectra from a radical pair in complex II (Fig. 5),
and our HYSCORE spectra with known spectra from SQ
in the complex III Qi site (Fig. 7), has thus allowed most
of the SQ signal observed during NADH oxidation in
SMPs to be assigned. Quantification of the SQ signal in
the O2-rich samples shown in Fig. 4 gave estimated
values of ~ 52% occupancy (SQ per N2), decreasing to ~
41% in the presence of carboxin, and to ~ 15% in the
presence of both antimycin A and carboxin, indicating
that complex III makes the largest known contribution,
followed by complex II. Thus, while the aim of this study
was to characterise the SQ(s) present in complex I, only
limited and ambiguous evidence has been obtained for
these species. A minor, piericidin A-sensitive signal, ob-
served under high O2 partial pressures in AOX-SMPs
and SMPs in the presence of carboxin and antimycin A
may arise from complex I turnover—but it may also
arise from any other enzyme linked to the reduced ubi-
quinone pool. Since this signal (or, at least, a contribu-
tion to this signal) is observed in antimycin A-inhibited
Fig. 7 Comparison of 14N couplings in HYSCORE spectra of SMPs
and AOX-SMPs at 40 K. X-band spectra (a and b) were recorded at
g = 2.006 with a four-pulse sequence (π/2–τ–π/2–t1–π–t2–π/2–τ–
echo) with π/2 = 16 ns, π = 16 ns, τ = 116 ns, shot repetition time 2
ms. The intensity of the stimulated echo (c) was normalised to the
intensity of the cross peaks at [4.1, 1.6] MHz. Simulations (d) were
calculated as a single 14N nucleus coupled to a single electron spin,
with parameters Aiso = 0.54 MHz, T = − 0.2 MHz, κ = 0.425 MHz, η =
0.18 MHz (see Eq. 3 for calculation of quadrupole coupling
parameters). Antidiagonal lines are given for the 14N Larmor
frequency. Very similar data as in a were recorded for AOX-SMPs in
the presence of carboxin (Additional file 5, Figure S5); the data
shown here are for SMPs because of their higher signal to noise
ratio. No strongly coupled 14N nuclei were detected in the (−,+)
quadrant; for the entire (+,+) quadrant (including the 1H region), see
Figures S6 and S7 in Additional files 7 and 8, respectively
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SMPs (that have no oxidase activity, Fig. 6), complex I
turnover is not required for its presence—but nonethe-
less, it is absent when complex I is reduced by NADH
under anoxic conditions (Fig. 6), which should also re-
duce any other ubiquinone-linked enzyme. Therefore,
the results suggest that the signal arises from an inter-
action with O2, under the high O2 partial pressures used
here to sustain turnover. Non-catalytic oxidation of ubi-
quinol itself, or of the cofactors in complex I and other
enzymes, may allow the slow turnover of complex I, or
O2 may interact directly with bound quinones in com-
plex I or other enzymes to generate SQ species. The in-
crease of the g ~ 2 signal observed in AOX-SMPs
(Fig. 6) may result from an increased steady-state con-
centration of complex I SQs, but this interpretation
remains tentative. Alternatively, for example, AOX-
SMPs may harbour the increasing product of a cata-
lytic side reaction that either involves AOX or de-
pends strongly on the ubiquinone pool potential.
Therefore, we are unable to definitively assign any of
the g ~ 2 EPR signals observed to complex I.
Based on the demonstrable proton-pumping capacity
of the SMP and AOX-SMP preparations used here, we
expected that the gz component of the N2 cluster should
be split by magnetic interactions with complex I SQ
(SQNf). This phenomenon was not observed. Changes in
the region of the N2 gz component were observed but
required prolonged incubation with NADH, and the N2
gz signal intensity was not affected (Additional file 9,
Figure S8). Furthermore, they were concomitant with a
decrease in the complex II S3 signal and so are unlikely
to be associated with the N2 cluster of complex I. We
also did not observe a profound reduction of SQ signal
intensity at 16 K upon addition of uncouplers [8]
(Additional file 9, Figure S8). Our results question the
relevance of these features for complex I catalysis, al-
though we cannot unambiguously exclude that they only
appear under higher Δp values than were achieved here.
While our AOX-SMPs show a lower RCR than those
reporting to support N2 signal splitting, it is notable that
when the NADH:Q1 assay system was used, the RCR
value dropped to 1.2–1.5 but N2 splitting and the pres-
ence of SQNf were still reported [11].
Previous investigations of SQs in SMPs have been in-
consistent in their reasons for assigning SQs to complex I,
rather than to complexes II and III. Early studies (which
produced the most convincing SQ signal relative to the
Fe-S spectrum of complex I) did not inhibit complex II or
Fig. 8 Analysis of 14N couplings from antimycin A-inhibited AOX-SMPs: Quadrupole coupling parameters indicate the identity of 14N nuclei. a
Simulated HYSCORE spectrum of SMPs inhibited with carboxin and AOX-SMPs inhibited with carboxin and antimycin. Simulation of major 14N
cross peaks with Aiso = 1.00 MHz, T = 0.08 MHz, κ = 0.8 MHz, η = 0.6 MHz (Antimycin insensitive) and Aiso = 0.54 MHz, T = − 0.2 MHz, κ = 0.425 MHz,
η = 0.18 MHz (Antimycin sensitive). 14N cross peaks were simulated as two electron spins each coupled to a single 14N nucleus. See methods
(Eq. 3) for quadrupole coupling parameters. b Reported 14N quadruple coupling parameters for protein-bound SQs. The two observed sets of 14N
couplings from AOX-SMP are labelled on the basis of their antimycin A sensitivity (both species are carboxin insensitive). b was adapted from [37]
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III to ablate their SQs [8, 47] so it is likely that the SQ sig-
nals they observed were dominated by enzymes down-
stream of complex I, particularly complex III. Subsequent
studies, including those that relied on NADH:Q1 reduc-
tion, sought to address this issue [10, 11]. A confident
evaluation of the origins of the SQs observed by these
studies is difficult because complete EPR spectra were not
reported; comparisons of relative intensities were pre-
cluded, and the effects of the NADH:Q1 system on the Fe-
S cluster EPR spectrum left unclear. These studies re-
ported that treatment with carboxin, antimycin A and
myxothiazol (a complex III Qo site inhibitor) caused a de-
crease in total SQ concentration of ~ 50% [10], similar to
that observed in our AOX-SMP studies. In contrast, they
also determined that (even then) complex I SQs were ac-
cumulated to ~ 100% occupancy, with a substantial pro-
portion attributed to ‘SQNx’, an ill-defined additional
putative complex I SQ. The surprisingly high occupancy
may be attributed to SQ formation at the flavin by the
hydrophilic ubiquinone analogue [18]. The remaining SQ
signals were reported to be sensitive to canonical complex
I inhibitors such as rotenone and piericidin A during
NADH:O2 turnover. However, complex I inhibitors pre-
vent reduction of the Q-pool, so cannot definitively local-
ise any SQ to complex I. Finally, attempts to identify
complex I SQ species in proteoliposomes, a spectroscopic-
ally cleaner system, failed to observe more than a minute
fraction of the SQs attributed to complex I in SMPs, des-
pite their reasonable catalytic activity and membrane
coupling [12, 20]. This behaviour is consistent with our
proposal that the majority of SQ species observed in SMPs
do not, in fact, arise from complex I.
Conclusions
Despite substantial effort, there is currently no con-
sensus on the origins of SQs within the mitochondrial
membrane. The inconsistency of the EPR data pre-
sented over the past 40 years [13] is not least the re-
sult of the complicated nature of SMPs, which has
precluded unambiguous assignments of observed SQ
signals to individual components within the mito-
chondrial membrane. Here, we combined a chimeric
respiratory chain with advanced pulse EPR spectro-
scopic techniques to unambiguously assign the major
SQ species generated during NADH oxidation in
SMPs to respiratory complex III, with an additional
minor SQ species resulting from complex II. We con-
clude that in earlier studies these complex II and III
SQs were sometimes mistakenly assigned to complex
I, in the absence of the opportunity to conduct, at
the time, controlled inhibition studies, pulse EPR
measurements, or focused investigations with the na-
tive substrate. Although we observed a piericidin A-
sensitive SQ signal, which is amplified in the presence
of O2 and in AOX-SMPs relative to SMPs, and which
increases with prolonged turnover, we cannot defini-
tively assign this g ~ 2 signal to complex I. The future
of this work now lies in isolating any complex I SQ
from other g ~ 2 signals, to infer mechanistic infor-
mation on the role of ubiquinone in the complex I
energy coupling reaction from its local magnetic en-
vironment. This will necessitate conclusive assignment
of the SQ signal in antimycin A- and carboxin-
inhibited AOX-SMPs to complex I by using a spec-
troscopically clean system, such as complex I-AOX
containing proteoliposomes.
Methods
Preparation of AOX-SMPs and EPR samples
SMPs were prepared using a protocol adapted from [28].
Twenty millilitres of mitochondria (~ 50mg/mL) were
defrosted at 4 °C and divided equally into four 50-mL
centrifuge tubes. The volume of each sample was made
up to 45mL with SMP buffer (250 mM sucrose, 10 mM
Tris-SO4 (pH 7.0)), and the mitochondria were centri-
fuged at 16,000×g (16 min, 4 °C). The resulting pellets
were combined and homogenised in 40mL of SMP buf-
fer. The pH of the homogenised mitochondria suspen-
sion was adjusted to pH 9.0 with 2.5M Tris at 4 °C and
allowed to stand for 10 min, diluted to 180mL with
SMP buffer, and centrifuged at 48,000×g (20 min, 4 °C).
The mitochondria were then washed twice more in SMP
buffer and collected by centrifugation at 16,000×g (16
min, 4 °C). In total, 15 mM MgSO4 was added and each
45-mL sample was sonicated at 130W for a total of 2.5
min (15 s on, 60 s off). The sonicated mixture was cen-
trifuged at 36,000×g (20 min, 4 °C) then the supernatant
was centrifuged at 120,000×g for 30 min to collect the
SMPs. The final pellets were suspended and homoge-
nised in approximately 2 mL of SMP buffer, and 100 μL
aliquots at 20–30mg/mL were frozen at − 20 °C. Protein
concentrations were determined using the test-tube vari-
ation of the Pierce bicinchoninic acid (BCA) protein
assay kit (Thermo Fisher Scientific, UK).
The alternative oxidase (AOX) from Trypanosoma bru-
cei brucei was prepared and incorporated into SMP mem-
branes as described previously [24, 25]. A 100-μL sample
of SMPs was incubated with the desired quantity of AOX
(from a 3–5mg/mL stock) on ice for at least 30min. In-
hibitors were added from DMSO stocks to final con-
centrations of 100 μM (with the percentage of DMSO
kept constant in order to avoid erroneous interpret-
ation of solvent-induced radical scavenging [48]). A
total of 100 μL of sample was transferred to a 4.0 mm
(O.D.) quartz EPR tube (Wilmad) and incubated at
room temperature for 5 min. EPR samples were pre-
pared at 20–25 mg/mL of total SMP protein (~ 2.0–
2.5 μM complex I based on approximately 10%
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complex I content in SMPs [28]). To ensure turnover
was maintained until freezing, O2 was bubbled
through the sample in the EPR tube: samples were
placed under O2 flow for 30 s, NADH added to ap-
proximately 20 mM, and the samples were then mixed
under O2 flow for 5 s before being frozen by rapid
immersion in a cold bath (dry ice/acetone) and trans-
ferred to liquid N2 for storage.
NADH:O2 activity assays
Kinetic assays were performed with a temperature-
controlled Agilent Cary 100 UV-Vis spectrophotometer
by following the absorbance of NADH at 340 nm
(Δε340 = 6.22 mM
− 1 cm− 1). SMP activity assays were per-
formed in SMP buffer (250 mM sucrose, 10 mM Tris-
SO4 (pH 7.0)) at 32 °C using 30–50 μg/mL SMPs and
initiated by 200 μM NADH. Uncouplers (carbonyl cyan-
ide 3-chlorophenylhydrazone (CCCP) or gramicidin, a
mixture of gramicidin A, B, C, and D) were added from
DMSO stock solutions to 2 μM or 1 μM, respectively.
The rate of NADH oxidation in the presence and ab-
sence of uncoupler was used to calculate the respiratory
control ratio (RCR). Piericidin A, antimycin A, or asco-
furanone were added from DMSO stock solutions at
2 μM to inhibit NADH:O2 turnover.
Succinate:NAD+ activity assays
Reverse electron transfer (RET) assays followed the re-
duction of NAD+ by SMPs by monitoring the absorb-
ance at 340 nm. A total of 50–100 μg/mL SMPs were
added to SMP buffer at 32 °C. Forward electron transfer
was inhibited with 2 μM antimycin A (SMPs) or by an-
aerobic preparation (AOX-SMPs). In total, 1 mM NAD+
was added and the assay mixture incubated for 1 min.
Then 1mM MgATP and 10mM succinate were added
to initiate RET. The rate of RET was determined as the
maximum rate following succinate addition. Gramicidin
(5 μg/mL) or piericidin A (2 μM) was added to inhibit
the RET reaction.
ACMA proton-pumping assays
Proton-pumping assays were performed using an RF-
5301PC spectrofluorometer (Shimadzu) and the fluores-
cent dye 9-Amino-6-Chloro-2-Methoxyacridine (ACMA).
The 50 μg/mL SMPs/AOX-SMPs were added to a fluores-
cence cuvette containing ACMA buffer (10mM Tris-SO4,
50mM KCl (pH 7.5)) at 32 °C. ACMA was added at
0.5 μM from a DMSO stock solution. Valinomycin was
added at 0.1 μM to the buffer solution to diminish the
membrane potential (Δψ) contribution of Δp, allowing
ΔpH to build to dominate Δp. Proton pumping was initi-
ated by the addition of 500 μM NADH or 1mM MgATP.
ACMA fluorescence was monitored using an excitation
wavelength of 419 nm and an emission wavelength of 484
nm. Proton gradients were dissipated by addition of pieri-
cidin A (2 μM), antimycin A (2 μM), asocfuranone (2 μM),
alamethicin (15 μg/mL), or oligomycin (4 μM).
Measurement of Δp in SMPs and AOX-SMPs
Δp was measured by varying the potential of NADH:fu-
marate oxidoreduction during ATP hydrolysis as de-
scribed previously [28]. Rates were measured in
triplicate. The 100 μg/mL SMPs or AOX-SMPs in SMP
buffer were treated with 2 μM antimycin A (SMPs) or
incubated anaerobically (AOX-SMPs [24]) to inhibit res-
piration before the addition of 1 mM MgATP. Then, ca-
talysis was initiated by addition of NAD+ (1 mM),
NADH (100 μM), succinate (500 μM), and variable con-
centrations of fumarate (0.025 to 40mM). NADH con-
centrations were monitored at 340 nm. Δp can be
determined by using the different fumarate concentra-
tions to set different potentials via the NAD+ (− 0.335 V)
and fumarate (0.020 V) potentials, as per Eq. 1:
ΔE ¼ −0:335þ 0:020−RT
2F
ln
NADH½  Fumarate½ f g
NADþ½  Succinate½ f g : ð1Þ
The potential of zero net rate of catalysis, −2ΔE = 4Δp
(because complex I pumps 4 protons per two electrons),
therefore defines Δp [28].
EPR measurements
EPR measurements were performed using an X/Q-
band Bruker Elexsys E580 Spectrometer (Bruker BioS-
pin GmbH, Germany) equipped with a closed-cycle
cryostat (Cryogenic Ltd., UK) and X-band split-ring
resonator module (ER 4118X-MD5), or a Bruker
EMXMicro spectrometer with a helium flow cryostat
(Oxford Instruments, UK). All measurements were
performed at X-band (9.7 GHz). The magnetic field
was calibrated at room temperature with a Bruker
strong pitch standard (g = 2.0028). Baseline spectra of
the empty resonator, of samples containing only buf-
fer, as well as of oxidised complex I were found to be
identical; all the CW spectra presented have been
baseline subtracted. Continuous-wave EPR measure-
ment conditions were 100 kHz modulation frequency,
7 G modulation amplitude; other measurement condi-
tions are given in figure legends.
EPR simulations
All spectral simulations were performed using the Easy-
Spin package for MATLAB [49, 50]. To simulate
HYSCORE spectra, 14N parameters were determined ac-
cording to the spin Hamiltonian for an electron spin
(S = ½) coupled to a nuclear spin with I = 1, with the en-
ergy terms representing the electron Zeeman, nuclear
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þ SAI þ IQI; ð2Þ
where βe is the Bohr magneton, βn is the nuclear magne-
ton, S is the electron spin operator (with S = ½), I is the
nuclear spin operator (with I = 1 for 14N), g is the g
factor (for the semiquinone taken to be isotropic with
g = 2.006), gn is the nuclear g factor of
14N, B0 is the
static magnetic field vector. A is the hyperfine tensor,
with principal components of the diagonalized matrix
A = Ax,y,z = Aiso + T, where T = [−T, −T, 2 T] in axial
symmetry, as assumed here. Q is the nuclear quadru-
pole tensor, for I = 1:
Q¼κ
− 1−ηð Þ






where κ = e
2qQ
4ℏ and η are the asymmetry parameter
0 < η < 1, with 0 designating an axial symmetry and 1 a
rhombic symmetry.
Although 14N nuclei can produce up to 18 cross peaks,
the double quantum (dq±, dq∓) transitions dominate
powder HYSCORE spectra here (as is often the case),
giving rise to a single pronounced pair of cross peaks.
These cross peaks were simulated by varying the values
of the hyperfine parameters, Aiso and T, and the quadru-
pole components, κ and η. A was estimated from the
HYSCORE frequencies of the double quantum transi-





where νI is the nuclear Zeeman frequency. Approximate
values of the quadrupole coupling parameters were de-
termined using Eq. 5:
νdq ¼ 2 νeff þ κ2 3þ η2
  1
2; ð5Þ
where νeff = | νI ± A/2|, then refined further to better fit
the experimental data.
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